Kyverna Therapeutics, Inc.
Total Trades
8
Buys
6
Sells
1
Largest Trade
$1M+
Insiders
7
Institutional Funds
70
Inst. Value
$1M+
Activist Filings
9
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| SEIDENBERG BETH C | Director | BUY | $500K+ | 133K | $7.50 | Dec 22, 2025 |
| Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | BUY | $500K+ | 133K | $7.50 | Dec 22, 2025 |
| Walker Karen Marie | CTO | SELL | $100K–$500K | 24K | $12.20 | Dec 18, 2025 |
| Walker Karen Marie | CTO | EXERCISE | $100K–$500K | 24K | $4.83 | Dec 18, 2025 |
| Vida Ventures, LLC | 10% Owner | BUY | $1M+ | 253K | $22.00 | Feb 15, 2024 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | BUY | $1M+ | 450K | $22.00 | Feb 14, 2024 |
| GILEAD SCIENCES, INC. | 10% Owner | BUY | $1M+ | 910K | $22.00 | Feb 13, 2024 |
| Northpond Ventures III GP, LLC | Insider | BUY | $1M+ | 450K | $22.00 | Feb 12, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 70 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 4.1M | $1M+ | SH |
| Bain Capital Life Sciences Investors, LLC | 3.1M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 981K | $1M+ | SH |
| MORGAN STANLEY | 842K | $1M+ | SH |
| Propel Bio Management, LLC | 667K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 600K | $1M+ | SH |
| RFG Advisory, LLC | 445K | $1M+ | SH |
| AIGH Capital Management LLC | 407K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 252K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 223K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 219K | $1M+ | SH |
| Burkehill Global Management, LP | 200K | $1M+ | SH |
| Monashee Investment Management LLC | 195K | $1M+ | SH |
| Simplify Asset Management Inc. | 192K | $1M+ | SH |
| Peapod Lane Capital LLC | 184K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 178K | $1M+ | SH |
| Maven Securities LTD | 146K | $1M+ | SH |
| Squarepoint Ops LLC | 139K | $1M+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 135K | $1M+ | SH |
| BARCLAYS PLC | 130K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
4.9%
2.8M shares
Westlake BioPartners Fund I, L.P. ("Westlake Fund I")
SC 13G/A · Feb 6, 2026
6.3%
3.8M shares
GordonMD Global Investments LP
SC 13G · Nov 17, 2025
7.0%
3.1M shares
Westlake BioPartners Fund I, L.P. (“Westlake Fund I”)
SC 13G · Nov 12, 2024
8.8%
3.8M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Oct 10, 2024
5.5%
2.4M shares
SC 13D · May 3, 2024
11.1%
4.8M shares
SC 13G · Feb 22, 2024
1.0%
450K shares
SC 13G · Feb 20, 2024
9.0%
412.6M shares
Bain Capital Life Sciences Opportunities III, LP
SC 13G · Feb 14, 2024
7.4%
3.2M shares